LEADER 04415nam 2200961z- 450 001 9910557508803321 005 20231214133208.0 035 $a(CKB)5400000000044468 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/77149 035 $a(EXLCZ)995400000000044468 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDiagnosis and Treatment of Musculoskeletal Disorders 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (162 p.) 311 $a3-0365-2660-9 311 $a3-0365-2661-7 330 $aMusculoskeletal disorders are a serious burden for patients and modern society. In Europe alone, 100,000,000 individuals suffer from musculoskeletal disorders and 40,000,000 affected workers cause losses due to work absence and a productivity loss of EUR 12 billion per year. Worldwide, musculoskeletal disorders are the second most common cause of pain and disability. Adequate diagnosis and early initiation of treatment are key elements in the care for patients suffering from musculoskeletal disorders, yet, for many musculoskeletal disorders, diagnostic tests lack appropriate accuracy. Treatment of musculoskeletal disorders is challenging as the mechanisms causing the complaints and mechanisms of action for the available treatment options are largely unknown. Moreover, these mechanisms and effectiveness might depend on specific patients? characteristics and call for personalized strategies. This Special Issue invited researchers in the field to contribute to the state of the art in the diagnosis and treatment of musculoskeletal disorders. As many different healthcare professionals are involved in the diagnosis and treatment of musculoskeletal disorders, the Special Issue published high-quality studies from different areas of healthcare. Studies reporting on original research (e.g., randomized controlled trials, cohort studies), but also systematic literature reviews and meta-analyses within the scope of the Special Issue were considered. Given recent debates around the effectiveness of surgical interventions for musculoskeletal disorders and concomitant risks for adverse side-effects, intervention studies on non-surgical treatment options were prioritized. 606 $aMedicine$2bicssc 610 $aosteoarthritis 610 $ahip 610 $apain 610 $afootwear 610 $acase-crossover study 610 $amusculoskeletal disorders 610 $atherapeutic injections 610 $acompetence 610 $aknee osteoarthritis 610 $aradiography 610 $ageneral practitioner 610 $asecondary care physician 610 $adiagnosis 610 $apatellofemoral pain 610 $apatellofemoral osteoarthritis 610 $apharmaceuticals 610 $anutraceuticals 610 $asurgery 610 $along-term results 610 $aadolescent idiopathic scoliosis 610 $askip pedicle fixation 610 $a10 years 610 $aposterior fusion 610 $atype 2 diabetes 610 $aphysical examination 610 $aultrasound 610 $ashoulder pain 610 $aadhesive capsulitis 610 $asubacromial pain syndrome 610 $aknee 610 $aACL 610 $ainjury 610 $aKOOS 610 $asymptoms 610 $aknee pain 610 $aearly OA 610 $aillness perceptions 610 $aself-management strategies 610 $across-sectional study 610 $asurvey 610 $afemoral intercondylar notch 610 $aknee anatomy 610 $aACL prevention 610 $aACL risk factors 610 $arisk factor 610 $adance 610 $ahypermobility 610 $alumbar radicular pain 610 $aclinical practice guidelines 610 $aAGREE II 610 $atreatment 615 7$aMedicine 700 $aRunhaar$b Jos$4edt$01322914 702 $avan Middelkoop$b Marienke$4edt 702 $aRunhaar$b Jos$4oth 702 $avan Middelkoop$b Marienke$4oth 906 $aBOOK 912 $a9910557508803321 996 $aDiagnosis and Treatment of Musculoskeletal Disorders$93035258 997 $aUNINA